Castleark Management LLC Exact Sciences Corp Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $1.55 Million - $1.99 Million	-19,995 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$89.51 - $118.04 $962,680 - $1.27 Million	-10,755 Reduced 34.98%	19,995 $2.36 Million
Q1 2019 May 14, 2019	BUY	$61.98 - $96.5 $360,103 - $560,665	5,810 Added 23.3%	30,750 $2.66 Million
Q4 2018 Feb 12, 2019	SELL	$56.04 - $82.66 $381,072 - $562,088	-6,800 Reduced 21.42%	24,940 $1.57 Million
Q3 2018 Nov 15, 2018	BUY	$48.29 - $80.6 $1.53 Million - $2.56 Million	31,740 New	31,740 $2.51 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.